ENGLEWOOD, CO / ACCESSWIRE / October 6, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company (the "Company") focused on commercializing novel products that address significant patient needs today reported financial results for its fiscal fourth quarter 2020, for the three month period ending June 30, 2020.
Fourth Quarter Fiscal 2020 Financial Highlights
Commenting on the fourth quarter of fiscal 2020, Josh Disbrow, Chief Executive Officer of Aytu BioScience, stated "Revenue increased exponentially in Q4 2020, to $14.9 million, compared to $1.7 million for Q4 2019. It is important to note that this was the first full quarter of revenue from the combined Aytu and Innovus businesses, along with the Cerecor assets. Turning to the bottom line, adjusted EBITDA loss was reduced to just $1.7 million for Q4 2020, compared to a $3.7 million adjusted EBITDA loss for Q4 2019. On the balance sheet, with approximately $48.3 million in cash, cash equivalents and restricted cash after paying $15 million to fully extinguish the Deerfield balloon payment previously due January 2021, we have less than $1 million of debt, and at current spending levels, we believe we have sufficient runway to reach profitability."
Mr. Disbrow continued, "Taking a closer look at the top line, both of our revenue streams, from the Consumer Health and Rx segments, performed well. On the Consumer Health side, we generated $6.9 million in revenue, an increase compared to Q3. Contributing to those results was organic growth within our core Consumer Health product lines of diabetes care, sexual wellness and bladder health. Additionally, we strengthened our e-commerce business for Consumer Health. Furthermore, our newly launched Consumer Health product, Regoxidine, an over-the-counter foam formulation of minoxidil for hair regrowth, is on track to contribute revenue in excess of seven figures in its first twelve months from launch."
Mr. Disbrow added, "On the Rx side, revenue was $7.9 million, a significant increase compared to Q3. Contributing to Rx revenue was solid contribution from the pediatric franchise. Additional value was created with Natesto gaining preferred status on Express Scripts' national formulary and the Natesto spermatogenesis study results published in the Journal of Urology, both of which we expect to drive prescription growth in the coming quarters. Organic Rx growth was fueled by a relatively balanced contribution across our key products and improved sales execution. Despite the impact COVID has had on physician office access, Q4 represented a record revenue quarter for our Rx business and significant growth over the previous quarters. This is a strong statement about our field execution and clinical value of our products, and I'm pleased to see our call levels now picking back up to near normal in the current quarter to further drive prescription growth."
Mr. Disbrow concluded, "At $14.9 million in record quarterly revenue, with a narrowed Adjusted EBITDA loss, $48.3 million of cash, cash equivalents and restricted cash on the balance sheet, the addition of the Healight opportunity for COVID-19 and future potential non-COVID-19 applications, and our addition to the Russell 2000, we have strong momentum to grow shareholder value in fiscal 2021 and onward."
Conference Call Information
The company will host a live conference call at 4:30 p.m. ET today. The conference call can be accessed by dialing either:
877-407-9124 (toll-free)
201-689-8584 (international)
The webcast will be accessible live at https://www.webcaster4.com/Webcast/Page/2142/37506 and archived on Aytu BioScience's website, within the Investors section under Events & Presentations, at aytubio.com, for 90 days.
A replay of the call will be available for fourteen days. Access the replay by calling 1-877-481-4010 (toll-free) or 919-882-2331 (international) and using the replay access code 37506.
About Aytu BioScience, Inc.
Aytu BioScience is a commercial-stage specialty pharmaceutical company focused on commercializing novel products that address significant patient needs. The company currently markets a portfolio of prescription products addressing large primary care and pediatric markets. The primary care portfolio includes (i) Natesto, the only FDA-approved nasal formulation of testosterone for men with hypogonadism (low testosterone, or "Low T"), (ii) ZolpiMist, the only FDA-approved oral spray prescription sleep aid, and (iii) Tuzistra XR, the only FDA-approved 12-hour codeine-based antitussive syrup. The recently acquired Pediatric Portfolio includes (i) Cefaclor, a second-generation cephalosporin antibiotic suspension; (ii) Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions; and (iii) Poly-Vi-Flor and Tri-Vi-Flor, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various for infants and children with fluoride deficiency. Aytu also distributes a COVID-19 IgG/IgM rapid test. This antibody test is a solid phase immunochromatographic assay used in the rapid, qualitative and differential detection of IgG and IgM antibodies to the 2019 Novel Coronavirus in human whole blood, serum or plasma. Aytu has also licensed the Healight Platform Technology. Healight is a pre-clinical investigational device being studied as a potential treatment for COVID-19 in severely ill, intubated patients and potentially other respiratory illnesses.
Aytu also operates a consumer health subsidiary, Innovus Pharmaceuticals, Inc. ("Innovus"), a specialty pharmaceutical company licensing, developing, and commercializing safe and effective consumer healthcare products designed to improve health and vitality. Innovus commercializes over twenty consumer health products competing in large healthcare categories including diabetes, men's health, sexual wellness and respiratory health. The Innovus product portfolio is commercialized through direct-to-consumer marketing channels utilizing the company's proprietary Beyond Human marketing and sales platform.
Aytu's strategy is to continue building its portfolio of revenue-generating Rx and consumer health products, leveraging its focused commercial team and expertise to build leading brands within large therapeutic markets. For more information visit aytubio.com and visit innovuspharma.com to learn about the company's consumer healthcare products.
Forward-Looking Statement
This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, or the Exchange Act. All statements other than statements of historical facts contained in this presentation, are forward-looking statements. Forward-looking statements are generally written in the future tense and/or are preceded by words such as ''may,'' ''will,'' ''should,'' ''forecast,'' ''could,'' ''expect,'' ''suggest,'' ''believe,'' ''estimate,'' ''continue,'' ''anticipate,'' ''intend,'' ''plan,'' or similar words, or the negatives of such terms or other variations on such terms or comparable terminology. These statements are just predictions and are subject to risks and uncertainties that could cause the actual events or results to differ materially. These risks and uncertainties include, among others: market and other conditions, our ability to successfully commercialize Healight Platform Technology, our ability to obtain FDA approval for the Healight Platform Technology, the effectiveness of the Healight Platform Technology in treating patients with COVID-19 or other illnesses, our ability to adequately protect the intellectual property associated with the Healight Platform Technology, regulatory delays, the reliability of the Healight Platform Technology in killing viruses and bacteria, market acceptance of UV based medical devices, the regulatory and commercial risks associated with introducing the COVID-19 rapid tests, any delays in shipment that may impact our ability to distribute the COVID-19 rapid tests, any reputational harm we may incur if there are delays in receiving the shipment of the COVID-19 rapid tests, our ability to enforce the exclusivity provisions of the distribution agreements, the reliability of serological testing in detecting COVID-19, shipping delays and their impact on our ability to introduce the COVID-19 rapid tests, the ability of the COVID-19 rapid tests to accurately and reliably test for COVID-19, the manufacturers of the COVID-19 rapid tests' ability to manufacture such testing kits on a high volume scale, manufacturing problems or delays related to the COVID-19 rapid tests, our ability to satisfy any labelling conditions or other FDA or other regulatory conditions to sell the COVID-19 rapid test kits, the demand or lack thereof for the COVID-19 rapid test kits, our ability to obtain additional COVID-19 rapid tests to meet demand, our ability to secure additional tests if the manufacturers of the COVID-19 rapid tests are unable to meet demand, the effects of the business combination of Aytu and the Pediatric Portfolio and the recently completed merger ("Merger") with Innovus Pharmaceuticals, including the combined company's future financial condition, results of operations, strategy and plans, the ability of the combined company to realize anticipated synergies in the timeframe expected or at all, changes in capital markets and the ability of the combined company to finance operations in the manner expected, the diversion of management time on Merger-related issues and integration of the Pediatric Portfolio, the ultimate timing, outcome and results of integrating the operations the Pediatric Portfolio and Innovus with Aytu's existing operations, risks relating to gaining market acceptance of our products, obtaining or maintaining reimbursement by third-party payors for our prescription products, the potential future commercialization.
Contact for Media and Investors:
James CarbonaraHayden IR(646) 755-7412james@haydenir.com
Non-GAAP Financial Information
This press release contains a financial measure that does not comply with U.S. generally accepted accounting principles (GAAP), Non-GAAP Adjusted EBITDA. Non-GAAP Adjusted EBITDA excludes (i) amortization, (ii) depreciation, (iii) stock-based compensation, (iv) other expenses comprising net interest expense, (v) non-cash gains and/or losses recognized in the quarter or year due to changes in the fair value of certain of Aytu's financial liabilities, such as contingent consideration, derivative warrant liability, or certain exchanges of debt, (vi) bad debt expense, (vii) impairment of certain long-lived assets; (viii) one-time transaction costs and (ix) costs associated with the Company's Healight technology. Management believes these measures are useful to supplement its GAAP financial statements with this non-GAAP information because management uses such information internally for its operating, budgeting and financial planning purposes. In addition, Aytu believes these non-GAAP financial measures are useful to investors because they allow for greater transparency into the indicators used by management as a basis for its financial and operational decision making. Non-GAAP information is not prepared under a comprehensive set of accounting rules and therefore, should only be read in conjunction with financial information reported under U.S. GAAP when understanding Aytu's operating performance. A reconciliation between GAAP and non-GAAP financial information is provided in the financial statement tables below.
AYTU BIOSCIENCE, INC. AND SUBSIDIARIESConsolidated Statements of Operations
(Unaudited)
Three Months Ended June 30,
Revenues
Product revenue, net
License revenue, net
Total product revenue
Operating expenses
Cost of sales
Research and development
Selling, general and administrative
Selling, general and administrative - related party
Impairment of intangible assets
Amortization of intangible assets
Total operating expenses
Loss from operations
Other (expense) income
Other (expense), net
(Loss) / gain from change in fair value of contingent consideration
(Loss) on extinguishment of debt
Gain from warrant derivative liability
Total other (expense) income
Net loss
Weighted average number of shares outstanding ofcommon shares outstanding
Basic and diluted net loss per common share
AYTU BIOSCIENCE, INC. AND SUBSIDIARIESConsolidated Balance Sheets
Assets
Current assets
Cash and cash equivalents
Restricted cash
Accounts receivable, net
Inventory, net
Prepaid expenses and other
Other current assets
Total current assets
Fixed assets, net
Right-of-use asset
Licensed assets, net
Patents and tradenames, net
Product technology rights, net
Deposits
Goodwill
Total long-term assets
Total assets
AYTU BIOSCIENCE, INC. AND SUBSIDIARIESConsolidated Balance Sheets, Cont'd
Liabilities
Current liabilities
Accounts payable and other
Accrued liabilities
Accrued compensation
Debt
Contract liability
Current lease liability
Current portion of fixed payment arrangements
Current portion of CVR liabilities
Current portion of contingent consideration
Total current liabilities
Long-term contingent consideration, net of current portion
Long-term lease liability, net of current portion
Long-term fixed payment arrangements, net of current portion
Long-term CVR liabilities, net of current portion
Warrant derivative liability
Total liabilities
Read the original:
Aytu BioScience Announces Fiscal Q4 2020 Net Revenue of $14.9 Million, an Increase of 82% Sequentially, and 766% Year-Over-Year - BioSpace
- Is it Low T | Signs, Symptoms, and what you can do about Low T [Last Updated On: August 18th, 2024] [Originally Added On: April 16th, 2014]
- LANHAM BLACKWELL BABER, "Low T" - Video [Last Updated On: August 18th, 2024] [Originally Added On: April 16th, 2014]
- Federal Panel Schedules Hearing on Possible Creation of AndroGel Lawsuit Litigation in the Northern District of ... [Last Updated On: August 18th, 2024] [Originally Added On: April 17th, 2014]
- Low T - Video [Last Updated On: August 18th, 2024] [Originally Added On: April 17th, 2014]
- JWU Sugar Shack performance by Low T - Video [Last Updated On: August 18th, 2024] [Originally Added On: April 24th, 2014]
- The Truth of Low T - Video [Last Updated On: August 18th, 2024] [Originally Added On: April 27th, 2014]
- Low T Treatment Lawsuit | 1-800-504-FIRM | The Knoll Law Firm - Video [Last Updated On: August 18th, 2024] [Originally Added On: May 3rd, 2014]
- Low T High Risk? - Video [Last Updated On: August 18th, 2024] [Originally Added On: May 9th, 2014]
- Low T Drug Info - Video [Last Updated On: August 18th, 2024] [Originally Added On: May 9th, 2014]
- Low T Vitamin Formula Is The Fountain of Youth - Video [Last Updated On: August 18th, 2024] [Originally Added On: May 16th, 2014]
- Dallas LOW T Doctor - Video [Last Updated On: August 18th, 2024] [Originally Added On: May 16th, 2014]
- Low T in young men - Video [Last Updated On: August 18th, 2024] [Originally Added On: May 19th, 2014]
- Low T Doctor in Englewood - Video [Last Updated On: August 18th, 2024] [Originally Added On: May 19th, 2014]
- T LOW T - Video [Last Updated On: August 18th, 2024] [Originally Added On: May 24th, 2014]
- My Little Runaway - Video [Last Updated On: August 18th, 2024] [Originally Added On: May 25th, 2014]
- The Low T Alternative - Video [Last Updated On: August 18th, 2024] [Originally Added On: May 31st, 2014]
- Tampa Bay Low T Center Testosterone Pellets - Video [Last Updated On: August 18th, 2024] [Originally Added On: June 8th, 2014]
- Funny Stand Up Comedy Clips | Horror Stories Of "Low T"! - Video [Last Updated On: August 18th, 2024] [Originally Added On: June 12th, 2014]
- The Dyson Show - Number 466 - Video [Last Updated On: August 18th, 2024] [Originally Added On: June 12th, 2014]
- LJW Production - "Low T" Attorney - Video [Last Updated On: August 18th, 2024] [Originally Added On: June 21st, 2014]
- testim gel 1% for low t - Video [Last Updated On: August 18th, 2024] [Originally Added On: June 25th, 2014]
- closing low t - Video [Last Updated On: August 18th, 2024] [Originally Added On: June 27th, 2014]
- edwards low t - Video [Last Updated On: August 18th, 2024] [Originally Added On: June 29th, 2014]
- Anchor Sign LOW T - Video [Last Updated On: August 18th, 2024] [Originally Added On: July 2nd, 2014]
- Low T Wonder Therapy Comes with Warning - Video [Last Updated On: August 18th, 2024] [Originally Added On: July 13th, 2014]
- Can WOMEN Suffer From "Low T"? Get The FACTS! - Video [Last Updated On: August 18th, 2024] [Originally Added On: July 16th, 2014]
- HD Deep Low T - Casablanca ( Morocco Dinara Primova's eyes ) - Video [Last Updated On: August 18th, 2024] [Originally Added On: July 18th, 2014]
- Low T Institute- St. Louis - Video [Last Updated On: August 18th, 2024] [Originally Added On: July 23rd, 2014]
- ANDROGEL/LOW T HEART ATTACK LAW FIRM - Video [Last Updated On: August 18th, 2024] [Originally Added On: July 25th, 2014]
- Episode 39: Karl Nadolsky: Part 2: What You Need to Know About Nutrition, Hormones and Supplements - Video [Last Updated On: August 18th, 2024] [Originally Added On: July 26th, 2014]
- Testosterone Drug Injury - Low T Heart Attack - Video [Last Updated On: August 18th, 2024] [Originally Added On: July 27th, 2014]
- Low Testosterone San Diego | 760-290-3552 | Low T Escondido - Video [Last Updated On: August 18th, 2024] [Originally Added On: July 27th, 2014]
- Low T Treatment West Palm Beach Florida 561 844 8188 - Video [Last Updated On: August 18th, 2024] [Originally Added On: August 3rd, 2014]
- Low T Treatment Wellington Florida 561 844 8188 - Video [Last Updated On: August 18th, 2024] [Originally Added On: August 3rd, 2014]
- Dr. Samadi Discusses Low T and "Manopause" - Video [Last Updated On: August 18th, 2024] [Originally Added On: August 8th, 2014]
- Prescription Testosterone Treatment (Low T) Alert - Video [Last Updated On: August 18th, 2024] [Originally Added On: August 10th, 2014]
- Feel young again by treating 'Low T': Mark Fierro interviews Dr. Christopher Asandra, M.D. - Video [Last Updated On: August 18th, 2024] [Originally Added On: August 13th, 2014]
- Cafe Be #26: Low T, Obama, Jihadi lunatics and aging when you least expect it - Video [Last Updated On: August 18th, 2024] [Originally Added On: August 23rd, 2014]
- Low T Public - Video [Last Updated On: August 18th, 2024] [Originally Added On: August 23rd, 2014]
- Testosterone Booster - Check Out wwwAndropauseGuide dot com To Eliminate Low T - Video [Last Updated On: August 18th, 2024] [Originally Added On: August 23rd, 2014]
- How To Increase Testosterone - Visit wwwAndropauseGuide dot com To Eliminate Low T - Video [Last Updated On: August 18th, 2024] [Originally Added On: August 23rd, 2014]
- Low T Symptoms - Visit wwwAndropauseGuide dot com To Solve Andropause - Video [Last Updated On: August 18th, 2024] [Originally Added On: August 30th, 2014]
- Man-Up: Give It a Shot internet commercial (Low T and E-D) - Video [Last Updated On: August 18th, 2024] [Originally Added On: August 30th, 2014]
- What is Low T and How Can You Fix It? - Video [Last Updated On: August 18th, 2024] [Originally Added On: August 30th, 2014]
- 30 Sec Low T Mass Tort Commercial - Burg Simpson - Video [Last Updated On: August 18th, 2024] [Originally Added On: September 1st, 2014]
- Papantonio: The Low T Cash Bonanza - Video [Last Updated On: August 18th, 2024] [Originally Added On: September 4th, 2014]
- FDA Disses Testosterone Boosters - Video [Last Updated On: August 18th, 2024] [Originally Added On: September 6th, 2014]
- Low T Treatment Palm Beach Gardens Florida 561 844 8188 - Video [Last Updated On: August 18th, 2024] [Originally Added On: September 7th, 2014]
- Low T Treatment Boynton Beach Florida 561 844 8188 - Video [Last Updated On: August 18th, 2024] [Originally Added On: September 7th, 2014]
- Low T Treatment Boca Raton Florida 561 844 8188 - Video [Last Updated On: August 18th, 2024] [Originally Added On: September 8th, 2014]
- Low T Treatment Jupiter Florida 561 844 8188 - Video [Last Updated On: August 18th, 2024] [Originally Added On: September 8th, 2014]
- Low T Treatment Delray Beach Florida 561 844 8188 - Video [Last Updated On: August 18th, 2024] [Originally Added On: September 8th, 2014]
- Lyme disease, Low T, Leptin and Belly Fat - Video [Last Updated On: August 18th, 2024] [Originally Added On: September 22nd, 2014]
- Know your T Number at Cratos Low T Clinic Colorado Springs - Video [Last Updated On: August 18th, 2024] [Originally Added On: September 26th, 2014]
- Gender Analysis 01. Low T: A Tale of Two Hormones - Video [Last Updated On: August 18th, 2024] [Originally Added On: September 30th, 2014]
- 4th Annual Boot Ride with Aaron Lewis and Sons of Anarchy! - Video [Last Updated On: August 18th, 2024] [Originally Added On: October 6th, 2014]
- SPECIAL REPORT: Drugs for 'Low T', Are%2 - Video [Last Updated On: August 18th, 2024] [Originally Added On: October 8th, 2014]
- STUPE LOW T SHIRT!!! - Video [Last Updated On: August 18th, 2024] [Originally Added On: October 22nd, 2014]
- Man-Up TV commercial (Low T and ED) - Video [Last Updated On: August 18th, 2024] [Originally Added On: October 26th, 2014]
- Apex PL Low T 30 - Video [Last Updated On: August 18th, 2024] [Originally Added On: October 26th, 2014]
- Apex Low T Therapy V2 30 - Video [Last Updated On: August 18th, 2024] [Originally Added On: October 26th, 2014]
- Phamacist Ben Fuchs, Testosterone, Low T, Muscle Building, Anabolism, Insulin, Low T Remedies - Video [Last Updated On: August 18th, 2024] [Originally Added On: October 26th, 2014]
- What Are The Symptoms of Low T and the Benefits of Testosterone Replacement? - Video [Last Updated On: August 18th, 2024] [Originally Added On: November 6th, 2014]
- The 3 Facts Every Man Must Know About Low T - Video [Last Updated On: August 18th, 2024] [Originally Added On: November 7th, 2014]
- Low T -Promo - Video [Last Updated On: August 18th, 2024] [Originally Added On: November 7th, 2014]
- "Low T" Testosterone Therapy Heart Risk Lawsuit - Video [Last Updated On: August 18th, 2024] [Originally Added On: November 12th, 2014]
- The Low T Book - A Man's 30 Day Guide To Improve Your S.E.L.F. - Video [Last Updated On: August 18th, 2024] [Originally Added On: November 15th, 2014]
- Low T ... A $2 Billion Testosterone SCAM? Manopause? - Video [Last Updated On: August 18th, 2024] [Originally Added On: November 22nd, 2014]
- Testosterone Lawsuit For Men With Side Effects From Low T Treatment - Video [Last Updated On: August 18th, 2024] [Originally Added On: December 5th, 2014]
- My 5 year fitness journy progress motivation thing... Low T, no TRT..Picture link in description - Video [Last Updated On: August 18th, 2024] [Originally Added On: December 5th, 2014]
- Low T:Me - Video [Last Updated On: August 18th, 2024] [Originally Added On: December 7th, 2014]
- Wim Yland Renault Low-T - Video [Last Updated On: August 18th, 2024] [Originally Added On: December 10th, 2014]
- Is MAP effective for low T? - Video [Last Updated On: August 18th, 2024] [Originally Added On: December 11th, 2014]
- Get low T - Video [Last Updated On: August 18th, 2024] [Originally Added On: December 15th, 2014]
- Low T Center supports Boot Campaign at Dallas Mavericks - Video [Last Updated On: August 18th, 2024] [Originally Added On: December 24th, 2014]
- Low Testosterone Therapy & Low T Doctors CHARLESTON, SC, 29407 - Video [Last Updated On: August 18th, 2024] [Originally Added On: December 25th, 2014]
- Low Testosterone Therapy & Low T Doctors CHARLESTON, SC, 29464 - Video [Last Updated On: August 18th, 2024] [Originally Added On: January 5th, 2015]
- Do You Have Low T?! How to Tell - Video [Last Updated On: August 18th, 2024] [Originally Added On: January 10th, 2015]
- Davis & Crump "Low T" - Video [Last Updated On: August 18th, 2024] [Originally Added On: January 10th, 2015]
- Find Out if You Have Low T Now - Video [Last Updated On: August 18th, 2024] [Originally Added On: January 15th, 2015]